Literature DB >> 7046454

Radiation-induced augmentation of the response of A/J mice to SaI tumor cells.

R E Anderson, S Tokuda, W L Williams, N L Warner.   

Abstract

Whole-body exposure of A/J mice to low doses (5-25 rads) of ionizing radiation immediately prior to the inoculation of 10(4) Sarcoma I (SaI) cells results in smaller tumors than are observed in sham-irradiated control animals. The irradiated group also contains a greater proportion of mice that fail to develop tumors or that demonstrate tumor regression. Low-dose augmentation is 1) less pronounced in recipients that have undergone splenectomy; 2) not evident in adult thymectomized-lethally irradiated-bone-marrow-restored (ATxXBM) animals, where the opposite effect is seen (eg, low-dose enhancement of tumor growth); and 3) abolished by the administration of normal syngeneic spleen cells unless the latter have been depleted of T cells. On this basis, a very radiosensitive T cell with suppressor activity is implicated in this phenomenon. Low-dose exposure at various times prior to tumor inoculation suggests that this cell regenerates in 5-10 days after irradiation.

Entities:  

Mesh:

Year:  1982        PMID: 7046454      PMCID: PMC1916018     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  In vivo splenic irradiation eradicates suppressor T-cells causing the regression and inhibition of established tumor.

Authors:  W E Enker; J L Jacobitz
Journal:  Int J Cancer       Date:  1980-06-15       Impact factor: 7.396

2.  Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes.

Authors:  T Umiel; N Trainin
Journal:  Transplantation       Date:  1974-09       Impact factor: 4.939

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

Review 5.  Immunological enhancement and inhibition of tumor growth: relationship to various immunological mechanisms.

Authors:  N Kaliss
Journal:  Fed Proc       Date:  1965 Sep-Oct

6.  Mouse thymic iso-antigens.

Authors:  A E Reif; J M Allen
Journal:  Nature       Date:  1966-01-29       Impact factor: 49.962

7.  Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.

Authors:  H Kirchner; A V Muchmore; T M Chused; H T Holden; R B Herberman
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

8.  Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.

Authors:  A E Eggers; J R Wunderlich
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

9.  Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.

Authors:  A J Treves; C Carnaud; N Trainin; M Feldman; I R Cohen
Journal:  Eur J Immunol       Date:  1974-11       Impact factor: 5.532

10.  Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.

Authors:  H Kirchner; T M Chused; R B Herberman; H T Holden; D H Lavrin
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  9 in total

1.  Potential treatment of inflammatory and proliferative diseases by ultra-low doses of ionizing radiations.

Authors:  Charles L Sanders
Journal:  Dose Response       Date:  2012-10-09       Impact factor: 2.658

2.  Global gene expression responses to low- or high-dose radiation in a human three-dimensional tissue model.

Authors:  Alexandre Mezentsev; Sally A Amundson
Journal:  Radiat Res       Date:  2011-04-12       Impact factor: 2.841

3.  The structural and functional assessment of cytotoxic injury of the immune system with particular reference to the effects of ionizing radiation and cyclophosphamide.

Authors:  R E Anderson; J C Standefer; S Tokuda
Journal:  Br J Cancer Suppl       Date:  1986

4.  The effects of cyclophosphamide and irradiation singly and in combination upon SaI growth in A/J mice.

Authors:  R E Anderson; W L Williams; S Tokuda
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

5.  Radiobiological basis for cancer therapy by total or half-body irradiation.

Authors:  Kiyohiko Sakamoto
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-10

Review 6.  Prenatal immunotoxicant exposure and postnatal autoimmune disease.

Authors:  S D Holladay
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

7.  Low dose irradiation permits immunization of A/J mice with subimmunogenic numbers of SaI cells.

Authors:  R E Anderson; S Tokuda; W L Williams; C W Spellman
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

Review 8.  Cancer immunotherapy: how low-level ionizing radiation can play a key role.

Authors:  Marek K Janiak; Marta Wincenciak; Aneta Cheda; Ewa M Nowosielska; Edward J Calabrese
Journal:  Cancer Immunol Immunother       Date:  2017-03-30       Impact factor: 6.968

9.  Low doses of ionizing radiation enhance angiogenesis and consequently accelerate post-embryonic development but not regeneration in zebrafish.

Authors:  Filipa G Marques; Lara Carvalho; Joana S Sousa; José Rino; Isabel Diegues; Esmeralda Poli; Filomena Pina; Leonor Saúde; Susana Constantino Rosa Santos
Journal:  Sci Rep       Date:  2020-02-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.